![Xiaoqi Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiaoqi Liu
Corporate Officer/Principal presso Trialspark, Inc.
Posizioni attive di Xiaoqi Liu
Società | Posizione | Inizio | Fine |
---|---|---|---|
Trialspark, Inc.
![]() Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Corporate Officer/Principal | 01/01/2023 | - |
Storia della carriera di Xiaoqi Liu
Precedenti posizioni note di Xiaoqi Liu
Società | Posizione | Inizio | Fine |
---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2021 | 01/12/2022 |
GELESIS INC | Corporate Officer/Principal | 01/07/2020 | 01/12/2021 |
Formazione di Xiaoqi Liu
Northwestern University | Graduate Degree |
Beijing Normal University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Cina | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
HALOZYME THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Trialspark, Inc.
![]() Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Finance |
Gelesis, Inc.
![]() Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Xiaoqi Liu
- Esperienza